What is the main business of Deep Trait?

The main business activity of Deep Trait focuses on research and experimental development on biotechnology.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on April 16, 2019.

Where is the headquarters located?

The headquarters is located at: ul. Bohdana Dobrzańskiego 3, 20-262 Lublin.

What is the share capital?

The share capital of the company is PLN 107,500 (approx. $29,038).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

The company reported a revenue of $6,395 in 2024, which is a decrease of 88.1% compared to 2023.

Yes, in 2024 the company achieved a net profit of $16.

Which cost dominates operating expenses?

The largest operating cost category falls under depreciation and amortization. This category amounted to $5,261 in 2024, representing 82% of all operating expenses.

DEEP TraitS.A.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2019-04-16

Share capital

107,500.00 PLN

Registered address

ul. Bohdana Dobrzańskiego 3, 20-262 Lublin, Poland

Website

deeptrait.ai

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 5 of 6 financial statements were filed late (the longest delay 867 days for 2022). 2 of 6 audited by a statutory auditor.

2025not filed
202428/11/2025
202328/11/2025
202228/11/2025
202120/09/2023
202027/01/2023

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue

This companyUSD 6.40kMedianUSD 55.24kAverageUSD 2.71m

Net profit

This companyUSD 15.81MedianUSD -1.27kAverageUSD -91.85k

Operating costs

This companyUSD 6.38kMedianUSD 65.85kAverageUSD 2.66m

Assets

This companyUSD 34.30kMedianUSD 133.19kAverageUSD 3.03m

Industry

Authorized Representatives

Ruslana Radchuk – Management Board Member

Sergii Shelpuk – President of the Management Board

Manner of representation

In the case of a multi-member management board, each member of the management board acting independently is authorized to make declarations of will on behalf of the company and represent the company.

Supervisory board

Aleksander Mokrecki – Supervisory Board Member

Ihor Kostiuk – Supervisory Board Member

Olha Romaniuk – Supervisory Board Member

Beneficial owners

Person	Rights

Bank accounts

Was a VAT taxpayer from 2019-04-19 to 2021-09-06.

Reason for removal: Art. 96 ust. 9 pkt 2 (contact with the taxpayer or their representative is impossible despite documented attempts)

Debt

No entries in the National Debtors Register (KRZ).

Public aid

Grant date	Purpose	Gross amount	Granting body
Aug 26, 2019	De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)	$4,558$4,558	Prezes Polskiej Agencji Rozwoju Przedsiębiorczości
Mar 7, 2019	Aid for SME access to finance — aid for start-ups	$208.3K$208,344	Dyrektor Narodowego Centrum Badań i Rozwoju

Competitors

Name	Revenue	Website
BiotechnaS.A.	$2,472,888.07	bsbiotechna.com
FcbiotechS.A.	$148,945.77	fcbiotech.pl
Microbe Plussp. z o.o.	$104,197.26	microbe-plus.com
Vitagenumsp. z o.o.	$9,376.94	vitagenum.pl
Meritrosp. z o.o.	$7,890.74	meritro.com
MAP Your Dna Spólka z Ograniczoną Odpowiedzialnościąsp. z o.o.	$7,283.38	mapyourdna.eu
Dairy Biotechnologiessp. z o.o.	$1,485.09	milcu.eu
ImmunotronicsP.S.A.	$0.16	immunotronics.net
Aiventrosp. z o.o.	$0.00	aiventro.com
Walletmed Heartsp. z o.o.	–	walletmed.com